Comparison between sitagliptin and nateglinide on postprandial lipid levels The STANDARD study英文文献资料.pdfVIP

Comparison between sitagliptin and nateglinide on postprandial lipid levels The STANDARD study英文文献资料.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Online Submissions: /esps/ World J Diabetes 2013 February 15; 4(1): -13 wjd@ ISSN 194-935 (online) doi:10.4239/wjd.v4.i1. © 2013 Baishideng. All rights reserved. BRIEF ARTICLE Comparison between sitagliptin and nateglinide on postprandial lipid levels: The STANDARD study Yuichi Kojima, Hideyoshi Kaga, Shinu Hayashi, Toru Kitazawa, Yuko Iimura, Makoto Ohno, Michiyasu Yoshitsugu, Mutsunori Fujiwara, Toru Hiyoshi Yuichi Kojima, Hideyoshi Kaga, Shinu Hayashi, Toru Kitaza- samples were collected at one and three hours after wa, Yuko Iimura, Makoto Ohno, Michiyasu Yoshitsugu, Mut- intake of a test meal. The primary outcome measure sunori Fujiwara, Toru Hiyoshi, Japanese Red Cross Medical was the area under the curve (AUC) of apolipoprotein Center, Tokyo 150-8935, Japan (Apo) B48 at three hours postprandially. Author contributions: Kojima Y, Kaga H, Hayashi S, Kitazawa T, Iimura Y and Fujiwara M contributed to research design; Ko- RESULTS: Twenty patients were randomly assigned jima Y, Ohno M, Yoshitsugu M and Hiyoshi T collected the data; Kojima Y wrote the manuscript; Kaga H, Hayashi S, Kitazawa to the sitagliptin group and sixteen patients were ran- T, Iimura Y, Ohno M, Yoshitsugu M, Fujiwara M and Hiyoshi T domized to the nateglinide group. All 36 patients took contributed to revising the manuscript; and all authors approved the medication as directed by the physician in both the final version. groups, and they all were analyzed. A

文档评论(0)

独角戏 + 关注
实名认证
文档贡献者

本人有良好思想品德,职业道德和专业知识。

1亿VIP精品文档

相关文档